GSK gets the vaccine edge on Pfizer
US experts favour GSK’s RSV vaccine over Pfizer’s, but both could be on the market soon.
CROI 2023 – progress on efforts to cure HIV
Aelix and Gilead, Immunocore and Corvus are all taking different approaches in the early hunt for a functional cure.
Spybiotech seeks new vaccines
With CMV in its sights, the Oxford University spinout is poised to take its novel VLP vaccine technology into the clinic.